mitoxantrone has been researched along with Congenital Familial Lymphedema in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breidenbach, M | 1 |
| Rein, D | 1 |
| Schmidt, T | 1 |
| Heindel, W | 1 |
| Kolhagen, H | 1 |
| Mallmann, P | 1 |
| Kurbacher, CM | 1 |
1 other study available for mitoxantrone and Congenital Familial Lymphedema
| Article | Year |
|---|---|
Intra-arterial mitoxantrone and paclitaxel in a patient with Stewart-Treves syndrome: selection of chemotherapy by an ex vivo ATP-based chemosensitivity assay.
Topics: Adenosine Triphosphate; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carc | 2000 |